Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Comparison With Other Growth Hormone Peptides MOD GRF 1-29 and Stabilized GHRH Analogs MOD GRF 1-29 (also known as CJC-1295 without DAC) is a shorter-acting GHRH analog that shares the same receptor mechanism as CJC-1295 but lacks the albumin-binding modification
This provides a metabolic connection between the methylation cycle and the livers major antioxidant and sulfur-conjugation systems
(capsule capsules) gelatin-free
The corresponding gene names for the target proteins were retrieved from the UniProt database ( Nephropathy or Diabetic Kidney Disease were used as keywords to screen targets in the Online Mendelian Inheritance in Man (OMIM) database ( Drugbank ( GeneCards database ( TTD and DisGeNET ( The intersection of metformin targets and DKD disease targets was mapped to identify potential therapeutic targets
All orders are intended strictly for scientific research usenot for human or veterinary consumption, diagnosis, or treatment
The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
